Potential mechanism of Huanglian Jiedu Decoction for treatment of hypertension based on network pharmacology / 中草药

ABSTRACT

Objective To study the mechanism of Huanglian Jiedu Decoction (HJD) in the treatment of hypertension by using network pharmacology. Methods Chemical components and targets related to the four herbs of Chinese meteria medica in HJD were searched through the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) to construct the interaction network diagram of the target point of the compounds. The hypertension related targets were screened through OMIM, TTD, and PharmGkb databases; The interactive target of HJD and hypertension was constructed in PPI database; GO analysis of screened core targets between drug target and disease target was carried out using Davidv 6.8 database, and the related pathways of core targets were enriched using KEGG database. Results Using the oral bioavailability (OB) ≥ 30% and drug likeness (DL) ≥ 0.18 as screening condition for the compounds, combined with supplement literatures searched, 61 active components and 154 corresponding protein targets of HJD were screened out. A total of 118 enrichment results were obtained from 228 core targets of HJD in hypertension, including 59 biological processes, 31 molecular functions, and 28 cell compositions. The selected targets were enriched by KEGG database and 45 pathways playing an important role in hypertension were screen out. Conclusion The synergetic effect of HJD with multi-components and multi-pathway was confirmed by network pharmacology, and the main possible mechanism of HJD in treating hypertension was predicted, which lay a foundation for the identification of effective components, the mechanism of action, and clinical application.